tiprankstipranks
Trending News
More News >
JW (Cayman) Therapeutics Co. Ltd. (HK:2126)
:2126
Advertisement

JW (Cayman) Therapeutics Co. Ltd. (2126) Similar Stocks

Compare
0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
JW (Cayman) Therapeutics Co. Ltd.
HK$2.98
HK$1.23B
64.32%
Alphamab Oncology
HK$7.49
HK$6.51B
39.93
247.62%
Lepu Biopharma Co. Ltd. Class H
HK$5.12
HK$8.90B
74.40%
Jiangsu Recbio Technology Co., Ltd. Class H
HK$7.71
HK$3.70B
-14.05%
0 Buy
0 Hold
0 Sell
Hold
CStone Pharmaceuticals
HK$5.59
HK$6.98B
337.10%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$18.20
HK$10.45B
110.03
87.02%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2126
JW (Cayman) Therapeutics Co. Ltd.
3.04
1.19
64.32%
HK:9966
Alphamab Oncology
8.03
5.72
247.62%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.11
2.18
74.40%
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
7.71
-1.26
-14.05%
HK:2616
CStone Pharmaceuticals
5.42
4.18
337.10%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
17.00
7.92
87.22%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis